A report stating that the Trump administration is close to reclassifying cannabis as a Schedule III drug—on par with mild painkillers—has the $32 billion industry hotly anticipating reform.Read more: https://t.co/cU5i6hGc0DPhoto: Jens Schlueter/AFP via Getty Images https://t.co/iY80nS13ak ...

Brandon Gomez, tell us more about cannabis stocks today. Hey, Scott. Yeah, look, it was a massive surge in cannabis names.We've been here before, though. Trump once again voicing his support to reclassify cannabis as a less dangerous drug. Now, this would align it with steroids or Tylenol with codine rather than more dangerous drugs like heroin LSD.Now, it could blaze a new trail for the industry, but investors shouldn't light up with celebration just yet. Despite Trump saying today that a decision could co ...